A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan

Tropical Medicine and International Health

Volumn 5, Issue 5, 2000, Pages 312-317

  Veeken, Hans ^a   Ritmeijer, Koert ^a   Seaman, Jill ^a   Davidson, Robert ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

Kala azar; Pentavalent antimonials; Randomised trial; Sodium stibogluconate; Treatment; Visceral leishmaniasis

Indexed keywords

GENERIC DRUG; STIBOGLUCONATE SODIUM;

ADULT; ARTICLE; CALCULATION; DRUG COST; DRUG MANUFACTURE; FEMALE; FOLLOW UP; HUMAN; LEISHMANIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; SUDAN; TREATMENT OUTCOME; TREATMENT PLANNING; VISCERAL LEISHMANIASIS;

ADULT; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEISHMANIASIS, VISCERAL; MALE;

EID: 0034095716     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2000.00555.x     Document Type: Article

References (7)

1. Moore E, O'Flaherty D, Heuvelmans H et al. (2000) A randomised comparison of generic sodium stibogluconate (sodium antimony gluconate, Albert David Ltd., Calcutta) and Pentostam (Glaxo Welcome, London) for the Treatment of Visceral Leishmaniasis In Kenya. Bulletin of WHO, in press.
2. Seaman J, Pryce D, Sondorp E, Moody A, Bryceson ADM & Davidson RN (1993) Epidemic visceral leishmaniasis in Sudan: a randomised trial of amłnosidine plus sodium stibogluconate versus sodium stibogluconate alone. Journal of Infectious Disease 168, 715-720.
3. Seaman J, Mercer A & Sondorp E (1996a) The epidemic of visceral leishmaniasis in Western Upper Nile, Southern Sudan: course and impact from 1984 to 1994. International Journal of Epidemiology 25, 862-871.
4. Seaman J, Mercer A, Sondorp E & Herwaldt B (1996b) Epidemic visceral leishmaniasis in Southern Sudan: treatment of severely debilitated patients under wartime conditions with limited resources. Annals of Internal Medicine 124, 664-672.
5. Sundar S, Sinha PR, Agrawal NK et al. (1998) A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. American Journal of Tropical Medicine and Hygiene 59, 139-143.
6. UNDP/World Bank/WHO (1997) Progress 1995-96: 13th program report of the UNDP/World Bank/WHO special program for research and training in tropical diseases. World Health Organization, Geneva.
7. WHO (1996) Manual on Visceral Leishmaniasis Control. World Health Organization, Geneva.